Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. (AIMLF) is a pioneering company in the artificial intelligence (AI) and machine learning (ML) sectors, dedicated to acquiring and advancing technologies that address critical societal needs. Established to capitalize on the burgeoning fields of AI and ML, the company focuses on emerging digital health and wellbeing solutions that leverage AI, cloud computing, and digital platforms to revolutionize healthcare management.
AI/ML Innovations Inc. is committed to transforming healthcare through strategic partnerships and innovative initiatives. Its majority-owned subsidiary, Health Gauge Inc., is at the forefront of health tech innovation. Health Gauge has developed the ‘Follow Your Heart’ smartwatch, a wellness tool that uses proprietary AI PrecisionPulse Neural Network measurement technology to provide non-invasive, medical-grade accurate blood pressure readings. This product is a significant step forward in addressing the hypertension epidemic, offering users convenient and precise health monitoring.
In addition to consumer products, AI/ML Innovations Inc. supports healthcare innovators and researchers with advanced tools like The Pulse Guru, a smart sensor wearable that offers unparalleled access to raw ECG and PPG signal data. This device is instrumental for professionals needing detailed cardiovascular insights.
The company’s strategic growth also includes a recent acquisition of Naiad Labs Inc.’s product division, integrating the Long ECG Neural Net, which drastically reduces the time needed to label long ECGs, enhancing accuracy and efficiency in cardiovascular diagnostics.
AI/ML Innovations Inc. continues to expand its technological footprint with the launch of NeuralCloud Solutions Incorporated, a subsidiary focused on merging smart sensor technology with digital health. The company aims to make high-quality personal biometric data accessible to individuals globally, supported by robust AI and neural network technologies.
AI/ML Innovations Inc. trades on the Canadian Securities Exchange under the symbol AIML, the OTCQB Venture Market under AIMLF, and the Frankfurt Stock Exchange under 42FB. For more information, visit the company's website.
AI/ML Innovations Inc. (AIMLF) has announced the launch of its subsidiary Tech2Heal SAS's Alakin ARPC Platform, a comprehensive solution for remote patient care. This 'third-generation' platform enhances patient engagement and streamlines workflows for healthcare providers, addressing limitations found in conventional monitoring systems. Alakin, which complies with HIPAA and supports FHIR standards, offers features such as telemedicine, scheduling management, and a multilingual mobile app. Its flexibility accommodates various healthcare settings, from oncology to primary care, ultimately aiming to improve patient outcomes.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced on January 4, 2023, that its subsidiary, Health Gauge Inc., is considering enforcement actions regarding its patent rights for a personal health monitoring solution. The company holds US Patent No. 11183303, which covers multiple wearable health monitor configurations and methods for analyzing health metrics. Tim Daniels, Chairman, indicated potential infringement by industry participants, highlighting the significant market value of wearable health tech in the US, estimated at several billion dollars annually.
AI/ML Innovations Inc. has engaged Octagon Media Corp for a four-month marketing services agreement to support its digital media campaign. The agreement involves a payment of US$60,000, compensated through 800,000 common shares at CAD$0.10 each. Additionally, Octagon will receive options to purchase 300,000 shares at CAD$0.20. AI/ML focuses on AI and ML technologies for healthcare solutions, with investments in companies like Health Gauge and AI Rx Inc..
AI/ML Innovations Inc. has launched a warrant exercise incentive program to encourage the early exercise of up to 5,648,000 common share purchase warrants. This initiative aims to boost working capital through the exercise of Series 'B' and Series 'D' Warrants with repriced prices of $0.075 and $0.20, respectively. The early exercise period runs from December 19, 2022, to January 9, 2023. The company anticipates gross proceeds of up to $423,600 and plans to issue additional incentive warrants. The program requires approval from the Canadian Securities Exchange.
AI/ML Innovations Inc. (AIMLF) has announced the acquisition of the remaining 30% of Health Gauge Inc. (HGI) for 1,800,000 Incentive Warrants. AIML previously acquired 70% of HGI in August 2020, making this transaction significant for full ownership. The acquisition aligns with AIML's focus on advancing AI and machine learning in digital healthcare. The deal is subject to Exchange approval and aims to enhance AIML's capabilities in personal health monitoring systems.
AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) announced that the British Columbia Securities Commission has lifted the Management Cease Trade Order (MCTO) previously imposed on August 30, 2022. This decision follows the successful completion of the required filings for its annual and interim financial statements. The MCTO had delayed the company's trading activities due to late filings associated with a significant equity investment in Tech2Heal SAS. The company expressed gratitude to its shareholders and regulators, ensuring its commitment to financial transparency.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced a delay in filing its financial documents, resulting in a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC) effective August 30, 2022. The CEO and CFO are restricted from trading until the annual audited financial statements are filed. The company aims to file the necessary documents by October 28, 2022, while addressing accounting issues related to a France-based investee. It will continue issuing bi-weekly default status reports during this period.
AI/ML Innovations Inc. announced that the British Columbia Securities Commission granted a management cease trade order (MCTO) affecting its CEO and CFO due to delays in filing required financial statements for the year ended April 30, 2022. The Company expects to file all necessary documents by October 28, 2022. The interim financial statements for the period ended July 31, 2022, also remain incomplete due to these delays. The Company will continue to provide bi-weekly updates during this period and is addressing accounting issues related to a France-based investee.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF, FWB:42FB) announced a management cease trade order (MCTO) from the British Columbia Securities Commission due to delays in filing annual financial statements for the fiscal year ended April 30, 2022. As a result, the company also missed the deadline for interim filings due September 29, 2022. The company aims to file the required documents by October 28, 2022, while continuing to issue bi-weekly default reports. Failure to comply may lead to a cease trade order on its securities.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced that the British Columbia Securities Commission (BCSC) granted a management cease trade order (MCTO) on August 30, 2022. This order prohibits the CEO and CFO from trading the company's securities until the filing of required audited financial statements for the year ending April 30, 2022. The company aims to file these documents by October 28, 2022, and will issue bi-weekly updates while in default. The MCTO does not hinder other shareholders from trading their securities.
FAQ
What is the current stock price of AI / ML Innovations (AIMLF)?
What is the market cap of AI / ML Innovations (AIMLF)?
What does AI/ML Innovations Inc. do?
What is 'Follow Your Heart'?
What are the key features of The Pulse Guru?
What recent acquisitions has AI/ML Innovations Inc. made?
What is NeuralCloud Solutions Incorporated?
How does AI/ML Innovations Inc. plan to expand its market presence?
Where can I buy AI/ML Innovations Inc. products?
What is the Neural Net Store?
How does AI/ML Innovations Inc. support the healthcare industry?
What is the significance of the Long ECG Neural Net?
